FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042946852> ?p ?o ?g. }

• W2042946852 endingPage "285" @default.
• W2042946852 startingPage "280" @default.
• W2042946852 abstract "Background: Gene-modified tumor cell vaccines have shown efficacy in animal models of malignancy, including prostate cancer. Class I major histocompatibility complex (MHC) assembly and function in the cellular targets of such therapies is pivotal in determining the efficacy of specific cytokine-secreting tumor vaccines. Purpose To help guide development of genetically engineered vaccine therapy for human prostate cancer, potential immune resistance pathways were evaluated by analysis of class I MHC assembly in prostate cancer cells. Method: Class I MHC assembly in metastasis-derived human prostate cancer cell lines (LNCaP, PPC-1, DU-145, PC-3, and TSU) and a normal prostate-derived cell line (TP-2) were characterized by phenotypic, molecular, and functional assays. Assembled class I MHC and antigen was measured by flow cytometry; mRNA levels of assembly components (class I MHC heavy chain,; β2-microglobulin, and the antigen transporter gene product TAP-2) were determined; and antigen processing was measured with a chimeric reconstituted system using vaccinia vectors. Restoration of antigen processing was attempted by interferon gamma stimulation and by transfection with mouse class I MHC heavy-chain cDNA. Results : Assembled class I MHC was underexpressed in two (LNCaP and PPC-1) of five prostate cancer cell lines compared with normal prostate-derived controls. PPC-1 cells underexpressed TAP-2 mRNA despite abundant class I MHC and β2-microglobulin message. Induction of TAP-2 by interferon gamma indicated that coding sequences for TAP-2 message were present in PPC-1. Resistance to cytotoxic T lymphocytes (CTL) lysis showed a functional defect in antigen transport by PPC-1 cells; reversal of the molecular defect with interferon gamma led to restoration of functional antigen processing. In contrast, LNCaP cells had competent antigen transport but deficient class I MHC heavy-chain function despite abundant class I MHC RNA; though refractory to stimulation by interferon gamma, this defect responded to transfection of class I MHC heavy-chain cDNA. Conclusions : Metastatic prostate cancer cells can escape T-cell recognition via divergent mechanisms of defective class I MHC assembly. The specific under-expression of TAP-2 gene product in PPC-1 cells contrasts with prior studies of TAP gene underexpression in lung cancer (which concurrently underexpressed class I MHC heavy chain) and provides evidence for a regulatory pathway controlling TAP-2 gene expression in human cancers that may not affect class I MHC heavy-chain expression- Implications:In clinical application of gene therapy for prostate cancer, these findings provide a rationale for focusing on strategies that can circumvent sole reliance on class I MHC-mediated tumor cell recognition by CTL. [J Natl Cancer Inst 87: 280–285, 1995]" @default.
• W2042946852 created "2016-06-24" @default.
• W2042946852 creator A5004417664 @default.
• W2042946852 creator A5009605331 @default.
• W2042946852 creator A5020674505 @default.
• W2042946852 creator A5021386247 @default.
• W2042946852 creator A5055290282 @default.
• W2042946852 creator A5061987607 @default.
• W2042946852 creator A5066707073 @default.
• W2042946852 date "1995-02-15" @default.
• W2042946852 modified "2023-09-23" @default.
• W2042946852 title "Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer" @default.
• W2042946852 cites W1421091744 @default.
• W2042946852 cites W1488558875 @default.
• W2042946852 cites W1556149314 @default.
• W2042946852 cites W1773381788 @default.
• W2042946852 cites W1991148746 @default.
• W2042946852 cites W1994435196 @default.
• W2042946852 cites W2024894669 @default.
• W2042946852 cites W2030005722 @default.
• W2042946852 cites W2045724858 @default.
• W2042946852 cites W2055034075 @default.
• W2042946852 cites W2076479500 @default.
• W2042946852 cites W2091691801 @default.
• W2042946852 cites W2100058438 @default.
• W2042946852 cites W2147701669 @default.
• W2042946852 cites W2149366474 @default.
• W2042946852 cites W2160015737 @default.
• W2042946852 cites W2423112668 @default.
• W2042946852 cites W2612386678 @default.
• W2042946852 doi "https://doi.org/10.1093/jnci/87.4.280" @default.
• W2042946852 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2104544" @default.
• W2042946852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7707419" @default.
• W2042946852 hasPublicationYear "1995" @default.
• W2042946852 type Work @default.
• W2042946852 sameAs 2042946852 @default.
• W2042946852 citedByCount "225" @default.
• W2042946852 countsByYear W20429468522012 @default.
• W2042946852 countsByYear W20429468522013 @default.
• W2042946852 countsByYear W20429468522014 @default.
• W2042946852 countsByYear W20429468522015 @default.
• W2042946852 countsByYear W20429468522016 @default.
• W2042946852 countsByYear W20429468522017 @default.
• W2042946852 countsByYear W20429468522018 @default.
• W2042946852 countsByYear W20429468522019 @default.
• W2042946852 countsByYear W20429468522020 @default.
• W2042946852 countsByYear W20429468522021 @default.
• W2042946852 countsByYear W20429468522022 @default.
• W2042946852 countsByYear W20429468522023 @default.
• W2042946852 crossrefType "journal-article" @default.
• W2042946852 hasAuthorship W2042946852A5004417664 @default.
• W2042946852 hasAuthorship W2042946852A5009605331 @default.
• W2042946852 hasAuthorship W2042946852A5020674505 @default.
• W2042946852 hasAuthorship W2042946852A5021386247 @default.
• W2042946852 hasAuthorship W2042946852A5055290282 @default.
• W2042946852 hasAuthorship W2042946852A5061987607 @default.
• W2042946852 hasAuthorship W2042946852A5066707073 @default.
• W2042946852 hasBestOaLocation W20429468522 @default.
• W2042946852 hasConcept C121608353 @default.
• W2042946852 hasConcept C126322002 @default.
• W2042946852 hasConcept C147483822 @default.
• W2042946852 hasConcept C203014093 @default.
• W2042946852 hasConcept C2776235491 @default.
• W2042946852 hasConcept C2780192828 @default.
• W2042946852 hasConcept C2781406297 @default.
• W2042946852 hasConcept C70721500 @default.
• W2042946852 hasConcept C71924100 @default.
• W2042946852 hasConcept C86803240 @default.
• W2042946852 hasConceptScore W2042946852C121608353 @default.
• W2042946852 hasConceptScore W2042946852C126322002 @default.
• W2042946852 hasConceptScore W2042946852C147483822 @default.
• W2042946852 hasConceptScore W2042946852C203014093 @default.
• W2042946852 hasConceptScore W2042946852C2776235491 @default.
• W2042946852 hasConceptScore W2042946852C2780192828 @default.
• W2042946852 hasConceptScore W2042946852C2781406297 @default.
• W2042946852 hasConceptScore W2042946852C70721500 @default.
• W2042946852 hasConceptScore W2042946852C71924100 @default.
• W2042946852 hasConceptScore W2042946852C86803240 @default.
• W2042946852 hasIssue "4" @default.
• W2042946852 hasLocation W20429468521 @default.
• W2042946852 hasLocation W20429468522 @default.
• W2042946852 hasLocation W20429468523 @default.
• W2042946852 hasOpenAccess W2042946852 @default.
• W2042946852 hasPrimaryLocation W20429468521 @default.
• W2042946852 hasRelatedWork W1497253641 @default.
• W2042946852 hasRelatedWork W1980245127 @default.
• W2042946852 hasRelatedWork W2042911820 @default.
• W2042946852 hasRelatedWork W2106003470 @default.
• W2042946852 hasRelatedWork W2147112642 @default.
• W2042946852 hasRelatedWork W2147707434 @default.
• W2042946852 hasRelatedWork W2475064925 @default.
• W2042946852 hasRelatedWork W2897445903 @default.
• W2042946852 hasRelatedWork W2969940106 @default.
• W2042946852 hasRelatedWork W4282843086 @default.
• W2042946852 hasVolume "87" @default.
• W2042946852 isParatext "false" @default.
• W2042946852 isRetracted "false" @default.
• W2042946852 magId "2042946852" @default.

• next